Topic dossier

Capital Markets

Debt and equity issuance, IPOs, bond and credit markets, and the funding conditions shaping UK and global business. How companies raise money, and what it signals about risk appetite, from the Briefed editorial archive.

Get this in your inbox — free Search the archive Back to topics

Linked stories

Latest edition

14 May 2026

Capital markets are where companies and governments raise money, and where the price of that money is set. Equity issuance, bond sales, and the credit conditions behind them are a constant read on risk appetite: when issuance is easy and cheap, confidence is high; when windows close and spreads widen, the system is pricing in trouble. For that reason the state of the capital markets is often a leading signal for the wider economy.

Several currents run through Briefed's coverage. The cost of borrowing, set by monetary policy and interest rates, decides who can raise debt and on what terms. The IPO market is a gauge of how much risk investors will take on a story rather than a track record. And the scale of private equity and private credit has shifted a growing share of financing away from the public markets entirely, changing how deals get done.

Briefed tracks the issuance, the pricing, and the conditions that open or shut the financing window. The coverage below follows the live activity; the structural read is that capital markets are an early warning system, worth watching because they move before the real economy does.

Coverage trail

41–57 of 57

14 May 2026Top Stories

Private equity retreats from India's billion-dollar deals

India's PE market has split in two: record deal volume but collapsing values as sponsors balk at seller prices. Q1 2026 saw 415 PE deals worth $9.1 billion, down 34% in value despite near-record transaction count, as Grant Thornton data shows. Only two billion-dollar deals closed versus seven in Q4 2025. Average deal size crashed to $21.8 million from $36.3 million as firms chase mid-market targets over growth-stage unicorns. IPO exits fell 78% in value, removing the liquidity premium that justified lofty entry multiples.

From Private equity cools on India as deal sizes shrink 34%

14 May 2026Top Stories

Malaysia's chip IPO hits 95x oversubscription as AI fever spreads

SkyeChip's IPO demand signals Asia wants its own NVIDIA proxies. The Penang-based chip designer drew 95x oversubscription for its public tranche, the largest retail demand since Petronas Chemicals in 2010. Malaysia's 2026 IPO proceeds are tracking toward $1.8 billion, the highest in 13 years, driven by tech listings and REIT spin-offs. Khazanah, EPF and other sovereign funds anchored the deal, betting on Malaysia's push to move beyond back-end semiconductor assembly into higher-value AI chip design. The frenzy mirrors Samsung's $1 trillion valuation spike as regional markets chase AI infrastructure plays.

From Private equity cools on India as deal sizes shrink 34%

14 May 2026Top Stories

AI capex binge overwhelms bond markets, pushes Alphabet overseas

Wall Street's AI financing machine is hitting capacity constraints. Alphabet's $17 billion bond sale was still being priced when the company started hawking additional debt, forcing underwriters to consider overseas markets to absorb the supply. The scale and clustering of AI infrastructure debt is straining even investment-grade credit markets as hyperscalers rush to fund data centers, chips and power systems. When the highest-quality borrower in tech needs to diversify funding sources, it signals the domestic corporate bond market is approaching saturation on AI-related issuance.

From Private equity cools on India as deal sizes shrink 34%

14 May 2026Tech & AI

Australia's PEP sweetens loan terms as leveraged credit tightens

Even top-tier sponsors are paying up in today's credit markets. Pacific Equity Partners, Australia's A$19 billion private equity giant, had to enhance pricing and protections on two portfolio company loans to clear syndication. The move signals a power shift toward lenders as Australian private debt yields push toward 5.75% all-in for leveraged transactions. PEP's Fund VII closed at A$3.2 billion hard cap last year and has deployed rapidly into large deals, but financing those buyouts now requires higher interest margins and tighter covenants than sponsors expected six months ago.

From Private equity cools on India as deal sizes shrink 34%

13 May 2026Markets & Economy

S&P upgrades India as foreign outflow fears prove overblown

India just earned its first sovereign rating upgrade in 18 years, rising to BBB from BBB-. S&P cited resilient domestic demand that makes foreign outflows and US tariff threats largely irrelevant for an economy driven by internal consumption. The timing is perfect: while Europe and the UK struggle with 1% growth, India is forecast to expand 7.1% in FY27. The upgrade should lower borrowing costs across Indian markets and boost investor confidence amid global uncertainty. Bond yields will likely fall and foreign institutional investment could reverse recent outflows. For global investors seeking diversification from slowing Western economies, India's structural story just got official validation.

From Memory makers name their price as shortage deepens

11 May 2026Markets & Economy

Hong Kong banks eye bad bank for $25bn soured debt

Hang Seng Bank and Bank of Communications are in early talks to create a special vehicle for offloading $25 billion in non-performing loans, a two-decade high representing 2 percent of total lending. The commercial real estate crisis has triggered a 224 percent jump in Hang Seng's property impairments to HK$2.5 billion, while HSBC's Hong Kong CRE exposure with significant risk tripled to $18.1 billion. Developer bond maturities spike 70 percent to $7.1 billion in 2026, creating a refinancing cliff that could force fire sales. The bad bank discussions signal lenders finally acknowledging what property valuations have already priced in: a structural reset, not a cycle.

From Trump calls Iran response 'totally unacceptable'

11 May 2026Markets & Economy

Cerebras eyes $160 IPO price on AI chip demand

The wafer-scale processor maker is reportedly considering raising its IPO price to $150-160 per share, up from an initial $115-125 range, as institutional demand builds for alternatives to Nvidia's dominance. Strong investor appetite has already pushed the company to revise targets twice in a week, potentially valuing the business above $30 billion compared to February's $23 billion private round. OpenAI appears as the dominant customer in SEC filings, creating concentration risk but also validating commercial traction. If Cerebras prices at the high end, it would mark the largest US tech IPO of 2026 and test whether public markets will pay premium valuations for specialized AI silicon.

From Trump calls Iran response 'totally unacceptable'

11 May 2026Tech & AI

Ex-Citadel quant triples China hedge fund assets

A former Asia quantitative research chief at Citadel Securities has more than tripled assets at his China-based hedge fund in recent months, capitalizing on strong performance as Beijing's regulatory crackdown on quants eases. The move reflects broader talent migration from Wall Street "pod shops" to domestic Chinese funds, as returnees tap diaspora networks and RMB financing channels. Citadel's own China expansion through QFII status and its $97 million settlement with regulators for 2015 trading irregularities shows the complexity of operating across jurisdictions. This trend matters because it signals capital formation shifting toward Chinese managers just as geopolitical tensions make Western fund access more uncertain.

From Trump calls Iran response 'totally unacceptable'

6 May 2026Top Stories

Sun Pharma's $12bn Organon bet doubles down on women's health

India's largest drugmaker is acquiring US-listed Organon for $14 per share, creating a $12.4 billion combined entity that positions Sun Pharma as a top-25 global pharmaceutical company. The all-cash deal assumes $8.6 billion in Organon debt while targeting the fastest-growing segments: biosimilars and women's health products across 100-plus markets. Organon's 30.7% EBITDA margins and established US presence offer Sun Pharma the scale to compete with Western giants, though integration risks loom large given the debt load. This marks India's biggest overseas pharma acquisition since independence, signalling confidence in demographic trends driving women's healthcare demand.

From Iran reopens Hormuz as oil plunges 10%

4 May 2026Top Stories

GameStop makes $56bn play for eBay in meme stock's wildest bet

Ryan Cohen thinks he can transform eBay into something worth hundreds of billions. GameStop's unsolicited $125-per-share offer values eBay at $56 billion with $20 billion in debt financing from TD Bank already secured. The meme stock darling holds $9 billion in cash against its $12 billion market cap, making this a bet-the-company move. Both firms pivot around collectibles and resale markets, but analysts see low probability of success given the massive dilution required. Cohen's compensation package rewards him for lifting GameStop to $100 billion. He is prepared for a proxy fight if eBay's board resists.

From Asia bleeds $7bn as Hormuz reopening talks stall

4 May 2026Markets & Economy

Asia bond surge marks strongest April in five years

A brief Iran ceasefire opened the floodgates for Asian issuance, delivering the region's strongest April in five years. Japan's 20-year government bond auction recorded its strongest demand since 2019 as elevated yields attracted global buyers amid Bank of Japan policy shifts. The World Bank issued a record HK$8 billion five-year benchmark, the largest HKD deal by an international issuer. Corporate miners like BHP and Rio Tinto rushed to market as spreads tightened. The window remains fragile: any resumption of Middle East tensions could reverse gains, with 10-year JGB yields hitting 2.5%, the highest since 1997.

From Asia bleeds $7bn as Hormuz reopening talks stall

4 May 2026Quick Hits

Block trade king Simon Sadler's insider trading trial begins

Segantii Capital's founder faces 25 days in Hong Kong court over alleged 2017 Esprit Holdings trades using Merrill Lynch tips. The firm returned $1 billion before shutting in 2024.

From Asia bleeds $7bn as Hormuz reopening talks stall

1 May 2026Top Stories

Seaport Therapeutics raises $255m for depression drugs that might work

The antidepressant maker priced its IPO at the top of the range, targeting a $912 million valuation for technology that promises oral bioavailability without the liver damage typical of neuropsychiatric drugs. Seaport's lead candidate SPT-300 advances into Phase 2b studies for major depression, with Goldman Sachs and JPMorgan underwriting the deal despite the company being barely two years old. The Glyph platform's ability to bypass first-pass metabolism could be genuinely disruptive, or it could be another biotech betting that novel delivery mechanisms will overcome the industry's 90% failure rate. Investors clearly believe the former, but Phase 2b data will settle the question.

From Singapore's PM to chair AI council as yen tanks 545 pips

1 May 2026Markets & Economy

Blue Owl draws $9bn but fee-paying assets disappoint

The alternative asset manager's headline capital raise masks a deeper problem: fee-paying assets increased by only $700 million, signaling limited near-term revenue impact from the inflows. Blue Owl is simultaneously executing a $2.7 billion secondary transaction on its Dyal fund, using $1 billion in equity and $1.7 billion in debt to boost distributions to 1.25x from 0.86x. The structure reflects growing demand for liquidity tools in private markets, but the gap between AUM growth and fee generation highlights the industry's dry powder problem. Investors want distributions, not just bigger balance sheets.

From Singapore's PM to chair AI council as yen tanks 545 pips

21 April 2026Markets & Economy

MTR tests Hong Kong dollar bond market revival

Hong Kong's MTR Corporation launched its first public HK dollar bond in three years, testing appetite for local currency debt as capital flight concerns ease. The transport operator is seeking HK$2 billion across 5- and 10-year tranches, with early indications showing strong institutional demand. This matters beyond MTR: if Hong Kong companies can access local funding again, it signals confidence in the peg and reduces dependence on offshore dollar markets.

From Apple names John Ternus CEO as Cook steps back

21 April 2026Policy & Regulation

MSCI delays Indonesia review after downgrade fears

MSCI postponed its Indonesia market classification review after foreign outflows hit $2.8 billion in January alone. The index provider was considering a downgrade from emerging to frontier market status due to new ownership restrictions on foreign investors. Indonesian officials lobbied hard for the delay, arguing that policy changes take time to implement. The reprieve gives Jakarta six months to prove it can balance nationalism with capital market access, but the underlying tension remains unresolved.

From Apple names John Ternus CEO as Cook steps back

8 April 2026Markets & Economy

FTSE keeps Indonesia on watch despite reforms

FTSE Russell postponed its March review of Indonesia's secondary emerging market status while monitoring capital market reforms, after MSCI warned of a potential downgrade in January. Indonesia completed key changes by April 3rd including doubling minimum free float to 15% and releasing detailed shareholder data. The Jakarta Composite has lost $120 billion since MSCI's warning, down over 17% year-to-date among Asia's worst performers. FTSE halted additions of new Indonesian stocks whilst maintaining corporate action updates, giving authorities breathing room until June's quarterly review.

From Oil crash, markets rally as Trump agrees Iran ceasefire

Capital Markets

Coverage trail

Follow Capital Marketswhere it actually matters.

Follow Capital Markets
where it actually matters.